Cortexin is a complex peptide preparation derived from the cerebral cortex of cattle or pigs, containing low-molecular-weight neuropeptides, amino acids, and trace minerals. Developed in Russia, Cortexin has been used clinically for various neurological conditions including stroke, traumatic brain injury, encephalopathy, and cognitive disorders. The preparation is believed to enhance neuronal metabolism, provide neuroprotection, and promote repair of damaged brain tissue. Like Cerebrolysin, Cortexin contains multiple bioactive peptide fragments that may work synergistically to support brain function. It is administered by intramuscular injection and has an established safety profile.
| Research Status | Approved in Russia |
|---|---|
| Half-Life | Variable |
| Administration | Intramuscular injection |
| Typical Dosage | 10 mg IM daily |
| Molecular Weight | < 10,000 Da (mixture of small peptides) |
| Molecular Formula | Variable mixture of peptides, amino acids, and minerals |
Neurotrophic and neuroprotective effects through multiple peptide components.
All information is presented for Research Use Only (RUO). Not medical advice.